atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer.
atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies.
Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies.
The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
Company Details
- Employees
- 28
- Founded
- 2018
- Address
- Rue De La Science 7, Aye,luxembourg 6900,belgium
- Phone
- +32 472 22 74 01
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- atbtherapeutics.com
- HQ
- Aye, Luxembourg
Atbtherapeutics Questions
Atbtherapeutics's helpline number is +32 472 22 74 01
Atbtherapeutics's website is atbtherapeutics.com
Atbtherapeutics's LinkedIn profile is https://be.linkedin.com/company/atbtherapeutics
Atbtherapeutics has
28 employees.
View email and phone details for 28
employees at Atbtherapeutics.
Atbtherapeutics's industry is
Biotechnology Research
Atbtherapeutics's top competitors are
Kailera Therapeutics,
Atalanta Therapeutics,
City Therapeutics,
Terray Therapeutics,
Triveni Bio,
Seaport Therapeutics,
A2 Biotherapeutics, Inc.,
Aspect Biosystems,
Aktis Oncology,
Avencell.
Atbtherapeutics's support email address is info@atbtherapeutics.com
Atbtherapeutics's categories are Biotechnology Research
Atbtherapeutics's founding year is 2018
